Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.73 GBX | +17.74% | +8.15% | -36.52% |
Apr. 22 | EARNINGS AND TRADING: Zenova's Kitemark award; Carnival's eyes savings | AN |
Apr. 18 | Aptamer inks new Optimer+ transplant rejection therapy partnership | AN |
Valuation
Fiscal Period: June | 2022 | 2023 |
---|---|---|
Capitalization 1 | 66.26 | 4.664 |
Enterprise Value (EV) 1 | 60.88 | 5.508 |
P/E ratio | -29.6 x | -0.59 x |
Yield | - | - |
Capitalization / Revenue | 16.4 x | 2.66 x |
EV / Revenue | 15.1 x | 3.14 x |
EV / EBITDA | -25.2 x | -1.07 x |
EV / FCF | -29,655,332 x | -1,206,174 x |
FCF Yield | -0% | -0% |
Price to Book | 8.23 x | 15.3 x |
Nbr of stocks (in thousands) | 69,023 | 69,092 |
Reference price 2 | 0.9600 | 0.0675 |
Announcement Date | 10/17/22 | 11/21/23 |
Income Statement Evolution (Annual data)
Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net sales 1 | 0.9867 | 0.8546 | 1.28 | 4.036 | 1.752 |
EBITDA 1 | -0.5402 | -0.8797 | -2.211 | -2.42 | -5.155 |
EBIT 1 | -0.5828 | -0.922 | -2.297 | -2.517 | -5.556 |
Operating Margin | -59.07% | -107.9% | -179.51% | -62.36% | -317.12% |
Earnings before Tax (EBT) 1 | -0.5948 | -0.9413 | -2.328 | -2.638 | -8.298 |
Net income 1 | -0.455 | -0.6747 | -1.849 | -2.093 | -7.836 |
Net margin | -46.11% | -78.96% | -144.51% | -51.86% | -447.26% |
EPS 2 | -0.009310 | -0.0120 | -1.154 | -0.0324 | -0.1135 |
Free Cash Flow | - | -0.1776 | - | -2.053 | -4.566 |
FCF margin | - | -20.78% | - | -50.86% | -260.63% |
FCF Conversion (EBITDA) | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - |
Dividend per Share | - | - | - | - | - |
Announcement Date | 12/16/21 | 12/16/21 | 12/16/21 | 10/17/22 | 11/21/23 |
Balance Sheet Analysis
Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | 0.84 |
Net Cash position 1 | 0.66 | 0.13 | 0.12 | 5.38 | - |
Leverage (Debt/EBITDA) | - | - | - | - | -0.1637 x |
Free Cash Flow | - | -0.18 | - | -2.05 | -4.57 |
ROE (net income / shareholders' equity) | - | -118% | - | -51.3% | -188% |
ROA (Net income/ Total Assets) | - | -41.4% | - | -23.2% | -48.7% |
Assets 1 | - | 1.632 | - | 9.037 | 16.1 |
Book Value Per Share 2 | 0.0200 | 0 | 0 | 0.1200 | 0 |
Cash Flow per Share 2 | 0.0100 | 0.0100 | 0.0100 | 0.1000 | 0 |
Capex 1 | 0.03 | 0.16 | 0.16 | 0.28 | 1.98 |
Capex / Sales | 2.85% | 18.21% | 12.35% | 6.86% | 112.73% |
Announcement Date | 12/16/21 | 12/16/21 | 12/16/21 | 10/17/22 | 11/21/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-36.52% | 4.27M | |
+5.85% | 32.93B | |
+20.16% | 7.94B | |
+30.81% | 4.19B | |
-25.95% | 2.8B | |
-19.96% | 1.38B | |
-31.87% | 1.17B | |
+8.02% | 966M | |
-35.73% | 900M | |
-25.74% | 839M |
- Stock Market
- Equities
- APTA Stock
- Financials Aptamer Group plc